Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: Prior work and current challenges

Osteoporosis International

Volumn 24, Issue 1, 2013, Pages 237-244

  Solomon, D H ^a   Mercer, E ^a   Woo, S B ^a   Avorn, J ^a   Schneeweiss, S ^a   Treister, N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bisphosphonate; Epidemiology; Osteonecrosis of the jaw; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ARTICLE; DATA BASE; DENTAL SURGERY; DISEASE ASSOCIATION; FRAGILITY FRACTURE; HEALTH INSURANCE; HUMAN; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; JAW OSTEONECROSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW;

BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; COHORT STUDIES; DIPHOSPHONATES; HUMANS; INCIDENCE; OSTEOPOROSIS;

EID: 84872319671     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-012-2042-6     Document Type: Article

References (23)

1. Drugs.com In http://www.drugs.com/top200-units-2009.html. Accessed 1 Jun 2012
2. Kolata G (2006) In: New York Times. New York. http://www.nytimes.com/ 2006/06/02/health/02jaw.html?scp=1&sq=osteonecrosis%20jaw%20kolata&st= cse. Accessed 1 Jun 2012
3. Yablonsky T (2006) Some drugs can lead to bone death. Chicago Tribune, Chicago
4. Bilezikian JP (2006) Osteonecrosis of the jaw - do bisphosphonates pose a risk? N Engl J Med 355:2278-2281
5. Marx RE (2008) Uncovering the cause of «phossy jaw» Circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed. J Oral Maxillofac Surg 66:2356-2363
6. AAOMS (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369-376
7. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100
8. Baillargeon J, Kuo YF, Lin YL, Wilkinson GS, Goodwin JS (2011) Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates. Ann Pharmacother 45:1199-1206
9. Pazianas M, Blumentals WA, Miller PD (2008) Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporos Int 19:773-779
10. Fellows JL, Rindal DB, Barasch A, Gullion CM, Rush W, Pihlstrom DJ, Richman J (2011) ONJ in two dental practice-based research network regions. J. Dent Res 90:433-438
11. Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415-423
12. Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68:243-253
13. Cartsos VM, Zhu S (1939) Zavras AI 2008 bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people. J Am Dent Assoc 139:23-30
14. Jeffcoat MK (2006) Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 21:349-353
15. Barasch A, Cunha-Cruz J, Curro FA, Hujoel P, Sung AH, Vena D, Voinea-Griffin AE, Beadnell S, Craig RG, DeRouen T, Desaranayake A, Gilbert A, Gilbert GH, Goldberg K, Hauley R, Hashimoto M, Holmes J, Latzke B, Leroux B, Lindblad A, Richman J, Safford M, Ship J, Thompson VP, Williams OD, Yin W (2011) Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dental Res 90:439-444
16. Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B (1939) Shuler CF 2009 oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry. J Am Dent Assoc 140:61-66
17. Hong JW, Nam W, Cha IH, Chung SW, Choi HS, Kim KM, Kim KJ, Rhee Y, Lim SK (2010) Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia. Osteoporos Int 21:847-853
18. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479-1491
19. Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N (2010) Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates. J Oral Maxillofac Surg 68:2241-2247
20. Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A (2007) Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol 78:1664-1669
21. Grant BT, Amenedo C, Freeman K, Kraut RA (2008) Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg 66:223-230
22. Lee CY, Suzuki JB (2009) CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I: biological concepts with a review of the literature. Implant Dent 18:492-500
23. Kunchur R, Need A, Hughes T, Goss A (2009) Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 67:1167-1173